RxDoctor Payments Data

Julie Sefcik, DO

Family Medicine · Westminster, CONPI 1558772624

Payments from drug & device makers

$682in general payments, 2019–2025

Across 29 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$153
  • Inspire Medical Systems, Inc.$102
  • GSK$67
  • AbbVie$62
  • Edwards Lifesciences$60
  • Dexcom, Inc.$48
  • plus $189 from 9 others

What the payments were for

  • Food & beverage$682100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$682 in reported general payments places this provider in the 75th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$37,294
Medicare patients
130
Services billed
684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$61,315
XareltoRivaroxaban44$57,696
EliquisApixaban26$43,032
Advair HfaFluticasone Propion/Salmeterol14$15,574
SymbicortBudesonide/Formoterol Fumarate11$5,915
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$4,334
Albuterol Sulfate HfaAlbuterol Sulfate117$3,987
Gabapentin148$3,424
Atorvastatin Calcium313$2,467
Fluoxetine Hcl55$2,440
Omeprazole89$2,214
Levothyroxine Sodium248$2,098
SynthroidLevothyroxine Sodium38$1,961
Metoprolol Succinate161$1,647
Lisinopril229$1,537

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$18$61,31533 claims
PfizerEliquis$17$43,03226 claims
AbbVieSynthroid$62$1,96138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Westminster

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →